½ÃÀ庸°í¼­
»óǰÄÚµå
1589495

¼¼°èÀÇ µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Digital Mammography Market by Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis), End-User (Diagnostic Centers, Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀº 2023³â 21¾ï 4,000¸¸ ´Þ·¯, 2024³â¿¡´Â 23¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.70%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 43¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ´Â ¿¢½º·¹ÀÌ Çʸ§ ´ë½Å µðÁöÅÐ ¼ö¿ëü¿Í ÄÄÇ»Å͸¦ »ç¿ëÇÏ¿© À¯¹æ Á¶Á÷¿¡ ¾ÏÀÇ Â¡Èİ¡ ÀÖ´ÂÁö °Ë»çÇÏ´Â À¯¹æ ¿µ»ó Áø´ÜÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. Àú¼±·®À¸·Î °íÈ­ÁúÀ» ¾òÀ» ¼ö Àֱ⠶§¹®¿¡ Áø´Ü ºÐ¾ß¿¡¼­ÀÇ Å« Áøº¸°¡ µÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ¸¾¸ð±×·¡ÇÇÀÇ Çʿ伺Àº ¾ÏÀÇ Á¶±â Áø´Ü¿¡ ÇʼöÀûÀÎ Á¤È®¼º°ú °ËÃâ·üÀ» Çâ»ó½ÃŰ´Â µ¥ ÀÖ½À´Ï´Ù. µðÁöÅÐ ¸¾¸ð±×·¡ÇÇÀÇ ¿ëµµ´Â Á¤±âÀûÀÎ À¯¹æ¾Ï °ËÁø°ú Ç¥Àû Áø´Ü ¹× ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô´Â º´¿ø, Áø´Ü¼¾ÅÍ, À¯¼± Àü¹® Ŭ¸®´Ð µîÀÌ Æ÷ÇԵ˴ϴÙ. µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ±â¼ú Çâ»ó, À¯¹æ¾Ï Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, À¯¹æ °Ç°­À» ÃËÁøÇÏ´Â Á¤ºÎÀÇ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê µîÀÌ ÀÖ½À´Ï´Ù. ÇコÄɾ À־ÀÇ ÀΰøÁö´ÉÀÇ º¸±ÞÀº È­»ó ÆÇµ¶ÀÇ Á¤¹Ðµµ¿Í ¼Óµµ¸¦ ³ôÀÏ ¼ö ÀÖ´Â AI žÀç Áø´Ü Åø µî, À¯¸ÁÇÑ ÀáÀç ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ½ÃÀåÀº µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ±â°èÀÇ ³ôÀº Ãʱ⠺ñ¿ë°ú ±â°è ÇØ¼®ÀÇ º¯µ¿°ú °ü·ÃµÈ ¹®Á¦¿Í °°Àº ÇѰ迡 Á÷¸éÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, °Ç°­ °ü¸®¿¡ ´ëÇÑ Á¢±Ù°ú ÀÚ¿øÀÇ °¡¿ë¼ºÀÇ °ÝÂ÷´Â ƯÈ÷ °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ º¸±ÞÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 21¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 23¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 43¾ï 6,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 10.70%

ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ±â¼ú Çõ½ÅÀº ºñ¿ë È¿À²ÀûÀÎ µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ¼Ö·ç¼Ç°ú Á¢±Ù¼ºÀ» ³ôÀÌ´Â ÈÞ´ë¿ë ±â±â¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ À§¾ç¼º°ú À§À½¼ºÀ» ÁÙÀ̰í Áø´Ü Á¤¹Ðµµ¸¦ Çâ»ó½Ã۱â À§ÇØ AI ¾Ë°í¸®ÁòÀÇ °³¼±À» À§ÇÑ Á¶»çµµ ÇÊ¿äÇÒ °ÍÀÔ´Ï´Ù. °í±Þ À̹ÌÁö ó¸® ±â¼úÀ» ÅëÇÕÇϱâ À§ÇØ ÇÏÀÌÅ×Å© ±â¾÷°ú Çù·ÂÇϰųª ÀúÀÚ¿ø ȯ°æ¿¡¼­ÀÇ Àü°³¿¡ º¸Á¶±ÝÀ» ³»±â À§ÇØ Á¤ºÎ ±â°ü°ú ÆÄÆ®³Ê½ÊÀ» ¸ÎÀ½À¸·Î½á ½ÃÀå ¹üÀ§¸¦ ´õ¿í È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ º»ÁúÀº ±â¼ú ¹ßÀü°ú °Ç°­ °ü¸® ¼ö¿ä Áõ°¡·Î °æÀïÀÌ Ä¡¿­ÇÏ°í ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº Â÷º°È­µÈ Á¦Ç°À» Á¦°øÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ°í ±â¼úÀÇ Áøº¸¿¡ º¸Á¶¸¦ ¸ÂÃß°í, »õ·Î¿î ÇコÄÉ¾î µ¿ÇâÀ̳ª À¯¹æÃÔ¿µ °ËÁø, ½ºÅ©¸®´×ÀÇ ÃËÁøÀ» À§ÇÑ Á¤Ã¥¿¡ Àü·«À» ¸ÂÃß´Â °ÍÀ¸·Î, ÀÌÀÍÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°è À¯¹æ¾Ï ȯÀÚ ¼ö Áõ°¡
    • À¯¹æ¾Ï¿¡ ´ëÇÑ Á¤ºÎÀÇ Àû±ØÀûÀÎ ´ëó
    • º¸°üÀ̳ª À̵¿ÀÌ ¿ëÀÌÇÔ¿¡ ÀÇÇÑ ¿ä±¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • 3D ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Çõ½ÅÀûÀÎ À̹Ì¡ ±â¼úÀÇ ÃâÇö
    • µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ¿¡ ÀΰøÁö´É ÅëÇÕ
  • ½ÃÀåÀÇ °úÁ¦
    • ¹æ»ç¼± ÇÇÆø À§Çè¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces´Â µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå °æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐ¸íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è À¯¹æ¾Ï ȯÀÚ ¼ö Áõ°¡
      • À¯¹æ¾Ï¿¡ ´ëÇÑ Á¤ºÎÀÇ ¹Ù¶÷Á÷ÇÑ ³ë·Â
      • º¸°ü ¹× À̵¿ÀÇ ¿ëÀÌÇÔ¿¡ ÀÇÇØ ¼ö¿ä°¡ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • 3D ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë
    • ±âȸ
      • Çõ½ÅÀûÀÎ È­»ó ±â¼úÀÇ ÃâÇö
      • µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ¿¡¼­ ÀΰøÁö´ÉÀÇ ÅëÇÕ
    • °úÁ¦
      • ¹æ»ç¼± ÇÇÆøÀÇ À§Çè¿¡ °üÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå : Á¦Ç°º°

  • 2D Ç® ÇÊµå µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ¸ð½Å¼¼½Ã½º
  • 3D Ç® ÇÊµå µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ¸ð½Å¼¼½Ã½º

Á¦7Àå µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Allengers Medical Systems Ltd.
  • Analogic Corporation
  • Bayer AG
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CMR Naviscan Corp.
  • CooperSurgical, Inc.
  • EIZO Corp.
  • Esaote SPA
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies Inc.
  • General Medical Merate SpA
  • Hologic Inc.
  • Konica Minolta Inc.
  • Koninklijke Philips NV
  • Merck & Co. Inc.
  • Metaltronica SpA
  • Planmed Oy
  • Siemens Healthineers GmbH
  • Toshiba Medical Systems Corporation
  • TRIVITRON Healthcare
  • Vannin Healthcare Global
BJH 24.11.21

The Digital Mammography Market was valued at USD 2.14 billion in 2023, expected to reach USD 2.35 billion in 2024, and is projected to grow at a CAGR of 10.70%, to USD 4.36 billion by 2030.

Digital mammography is a type of breast imaging that uses digital receptors and computers instead of X-ray film to examine breast tissue for cancerous signs. It represents a significant advancement in the diagnostic field due to its ability to offer better image quality with lower radiation doses. The necessity of digital mammography lies in its precision and improved detection rates, crucial for early cancer diagnosis. Its applications extend to routine breast cancer screenings and targeted diagnostics, with end-users including hospitals, diagnostic centers, and specialized breast clinics. Key growth factors in the digital mammography market include technological improvements, increased awareness regarding early breast cancer detection, and supportive governmental initiatives promoting breast health. The proliferation of artificial intelligence in healthcare offers promising potential opportunities, such as AI-powered diagnostic tools that can enhance image interpretation accuracy and speed. However, the market faces limitations including high initial costs of digital mammography machines and challenges related to machine interpretation variability. Furthermore, disparities in healthcare access and resource availability can hinder widespread adoption, particularly in developing regions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.14 billion
Estimated Year [2024] USD 2.35 billion
Forecast Year [2030] USD 4.36 billion
CAGR (%) 10.70%

To counter these challenges, innovation should focus on cost-effective digital mammography solutions and portable equipment that can increase accessibility. Research could also delve into improving AI algorithms to reduce false positives and negatives, enhancing diagnostic accuracy. Collaborating with tech companies for integrating advanced image processing technologies or forming partnerships with government entities for subsidized deployment in low-resource settings can further expand market reach. The nature of this market is highly competitive and rapidly evolving, driven by both technological advancements and increasing healthcare demands. Companies stand to benefit by investing in R&D to offer differentiated product offerings, keeping pace with technological strides, and aligning their strategies to emerging healthcare trends and policies geared towards promoting mammography check-ups and screenings.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Mammography Market

The Digital Mammography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in number of breast cancer cases worldwide
    • Favorable government initiatives for breast cancer
    • Increasing need owing to ease of storage and transferability
  • Market Restraints
    • High cost of 3D mammography system
  • Market Opportunities
    • Emergence of innovative imaging technologies
    • Integration of artificial intelligence in digital mammography
  • Market Challenges
    • Concern regarding the risk of exposure to radiation

Porter's Five Forces: A Strategic Tool for Navigating the Digital Mammography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Mammography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Mammography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Mammography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Mammography Market

A detailed market share analysis in the Digital Mammography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Mammography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Mammography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Mammography Market

A strategic analysis of the Digital Mammography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Mammography Market, highlighting leading vendors and their innovative profiles. These include Allengers Medical Systems Ltd., Analogic Corporation, Bayer AG, Canon Medical Systems Corporation, Carestream Health, Inc., CMR Naviscan Corp., CooperSurgical, Inc., EIZO Corp., Esaote SPA, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., General Medical Merate SpA, Hologic Inc., Konica Minolta Inc., Koninklijke Philips NV, Merck & Co., Inc., Metaltronica S.p.A, Planmed Oy, Siemens Healthineers GmbH, Toshiba Medical Systems Corporation, TRIVITRON Healthcare, and Vannin Healthcare Global.

Market Segmentation & Coverage

This research report categorizes the Digital Mammography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 2D Full Field Digital Mammography Tomosynthesis and 3D Full Field Digital Mammography Tomosynthesis.
  • Based on End-User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in number of breast cancer cases worldwide
      • 5.1.1.2. Favorable government initiatives for breast cancer
      • 5.1.1.3. Increasing need owing to ease of storage and transferability
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of 3D mammography system
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of innovative imaging technologies
      • 5.1.3.2. Integration of artificial intelligence in digital mammography
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding the risk of exposure to radiation
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Mammography Market, by Product

  • 6.1. Introduction
  • 6.2. 2D Full Field Digital Mammography Tomosynthesis
  • 6.3. 3D Full Field Digital Mammography Tomosynthesis

7. Digital Mammography Market, by End-User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals

8. Americas Digital Mammography Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Mammography Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Mammography Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allengers Medical Systems Ltd.
  • 2. Analogic Corporation
  • 3. Bayer AG
  • 4. Canon Medical Systems Corporation
  • 5. Carestream Health, Inc.
  • 6. CMR Naviscan Corp.
  • 7. CooperSurgical, Inc.
  • 8. EIZO Corp.
  • 9. Esaote SPA
  • 10. Fujifilm Holdings Corporation
  • 11. GE Healthcare Technologies Inc.
  • 12. General Medical Merate SpA
  • 13. Hologic Inc.
  • 14. Konica Minolta Inc.
  • 15. Koninklijke Philips NV
  • 16. Merck & Co., Inc.
  • 17. Metaltronica S.p.A
  • 18. Planmed Oy
  • 19. Siemens Healthineers GmbH
  • 20. Toshiba Medical Systems Corporation
  • 21. TRIVITRON Healthcare
  • 22. Vannin Healthcare Global
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦